Ray Ng
  1. Associate

Mr. Ng is an associate in Davis Polk's Corporate Department, resident in Hong Kong.

Work Highlights

  • Ocumension Therapeutics' $200.4 million HKIPO and global offering
  • Shenzhen Hepalink Pharmaceutical's $523 million HKIPO and global offering
  • NetEase's $3.1 billion Hong Kong secondary listing

Professional History

  • Davis Polk since 2017

Practice Focus

Bar Admissions

  • Hong Kong


  • B.A., University of Hong Kong, 2010
  • J.D., City University of Hong Kong School of Law, 2016
  • PCLL, City University of Hong Kong, 2017


  • Cantonese
  • Chinese
  • English